Nivolumab-Induced Secondary Sclerosing Cholangitis with Deterioration Despite Immunosuppression

被引：15
|
作者：
Anderson, Brady [1 ]
Dawe, David E. [1 ,2 ]
机构：
[1] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada
[2] CancerCare Manitoba, Dept Med Oncol & Hematol, Winnipeg, MB, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 09期
关键词：
D O I：
10.1016/j.jtho.2019.04.023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E205 / E206
页数：3
相关论文
共 50 条
  • [1] Nivolumab-induced sclerosing cholangitis: A case report and literature review
    McClure, T.
    Cui, W.
    Testro, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 37 - 37
  • [2] Case of nivolumab-induced sclerosing cholangitis: lessons from long-term follow-up
    McClure, Tess
    Cui, Wanyuan
    Asadi, Khashayar
    John, Thomas
    Testro, Adam
    BMJ OPEN GASTROENTEROLOGY, 2020, 7 (01):
  • [3] Clinical features, treatment, and outcome of nivolumab-induced cholangitis
    He, Yang
    Fan, Zhiqiang
    Sun, Wei
    Ouyang, Linqi
    Wang, Chunjiang
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2024, 46 (06) : 757 - 762
  • [4] Small duct-sparing nivolumab-induced cholangitis
    Teo, A. W. C.
    Atkinson, V.
    Britton, L.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 60 - 61
  • [5] A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy
    Hirasawa, Yuya
    Yoshimura, Kiyoshi
    Matsui, Hiroto
    Kubota, Yutaro
    Ishida, Hiroo
    Arai, Jun
    Sakaki, Masashi
    Oguro, Nao
    Shida, Midori
    Taniguchi, Makoto
    Hamada, Kazuyuki
    Ariizumi, Hirotsugu
    Ishiguro, Tomoyuki
    Ohkuma, Ryotaro
    Sambe, Takehiko
    Horiike, Atsushi
    Imamura, Chiyo K.
    Shiozawa, Eisuke
    Wada, Satoshi
    Tsurutani, Junji
    Iwamoto, Sanju
    Uchida, Naoki
    Kiuchi, Yuji
    Tate, Genshu
    Kobayashi, Shinichi
    Tsunoda, Takuya
    MEDICINE, 2021, 100 (23) : E25774
  • [6] Hyponatraemia secondary to nivolumab-induced primary adrenal failure
    Trainer, Harris
    Hulse, Paul
    Higham, Claire E.
    Trainer, Peter
    Lorigan, Paul
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2016,
  • [7] A case with life-threatening secondary sclerosing cholangitis caused by nivolumab
    Yoshikawa, Yuki
    Imamura, Michio
    Yamaoka, Kenji
    Kosaka, Yumi
    Murakami, Eisuke
    Morio, Kei
    Fujino, Hatsue
    Nakahara, Takashi
    Okamoto, Wataru
    Yamauchi, Masami
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Hayes, Clair Nelson
    Aikata, Hiroshi
    Fujitaka, Kazunori
    Arihiro, Kouji
    Hattori, Noboru
    Chayama, Kazuaki
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (01) : 283 - 287
  • [8] A case with life-threatening secondary sclerosing cholangitis caused by nivolumab
    Yuki Yoshikawa
    Michio Imamura
    Kenji Yamaoka
    Yumi Kosaka
    Eisuke Murakami
    Kei Morio
    Hatsue Fujino
    Takashi Nakahara
    Wataru Okamoto
    Masami Yamauchi
    Tomokazu Kawaoka
    Masataka Tsuge
    Akira Hiramatsu
    Clair Nelson Hayes
    Hiroshi Aikata
    Kazunori Fujitaka
    Kouji Arihiro
    Noboru Hattori
    Kazuaki Chayama
    Clinical Journal of Gastroenterology, 2021, 14 : 283 - 287
  • [9] Nivolumab-Induced Pneumonitis
    Chugh, Karan
    Jatwani, Karan
    Bhanot, Ravinder
    Dubaybo, Basim
    CHEST, 2016, 150 (04) : 678A - 678A
  • [10] Nivolumab-induced sialadenitis
    Takahashi, Saeko
    Chieko, Xu
    Sakai, Tetsuya
    Hirose, Shigemichi
    Nakamura, Morio
    RESPIROLOGY CASE REPORTS, 2018, 6 (05):
12345